Lobbying Disclosure: California Society of Health-System Pharmacists (Q2 2000)
June 20, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
This report identifies the financial investment made by a professional pharmacy organization to influence 19 specific pieces of California legislation and various hearings during the second quarter of 2000.
Potentially affected actors named in the source documents. Mention is not a position.
California Society of Health-System Pharmacists
The organization incurred costs to influence state legislative outcomes.
Flannery Group
The firm received payment to provide professional lobbying services.
Last recorded activity June 20, 2026.
Next step not available in the current record.
Summary
Key Facts
- The California Society of Health-System Pharmacists paid the Flannery Group $9,322.84 for lobbying services.
- The reporting period for these activities was April 1, 2000, to June 30, 2000.
- The lobbying activity focused on 11 Assembly Bills: AB 40, 256, 1496, 1847, 1915, 1979, 2018, 2106, 2294, 2394, and 2660.
- The lobbying activity focused on 7 Senate Bills: SB 466, 1339, 1761, 1875, 2007, 2074, and 2074.
- The lobbying activity included monitoring Assembly Concurrent Resolution (ACR) 105.
- The lobbying activity included participation in ICW hearings.
Why It Matters
This report identifies the financial investment made by a professional pharmacy organization to influence 19 specific pieces of California legislation and various hearings during the second quarter of 2000.
Frequently Asked Questions
How much did the California Society of Health-System Pharmacists spend on lobbying in this period?
What specific legislation was the focus of this lobbying?
News Coverage
Lobbying Activity
FLANNERY GROUP THE
on behalf of CALIFORNIA SOCIETY OF HEALTH-SYSTEM PHARMACISTS
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Historical Lobbying Data
This document provides a snapshot of pharmaceutical industry lobbying priorities in California during the second quarter of 2000.
Connected Entities
Sources
www.sos.ca.gov
Analysis Score
0–100- Significance30How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz5Current news / social attention level
Publisher tools